Abstract
Emerging reports of SARS-CoV-2 breakthrough infections entail methodical genomic surveillance for determining the efficacy of vaccines. This study elaborates genomic analysis of isolates from breakthrough infections following vaccination with AZD1222/Covishield and BBV152/Covaxin. Variants of concern B.1.617.2 and B.1.1.7 responsible for cases surge in April-May 2021 in Delhi, were the predominant lineages among breakthrough infections.
Keywords: COVID-19; SARS-CoV-2; genomic analysis; vaccine breakthrough infections; variants of concern.
All Keywords
【저자키워드】 COVID-19, SARS-CoV-2, variants of concern, Genomic analysis, vaccine breakthrough infections, 【초록키워드】 Efficacy, Vaccine, vaccination, Vaccines, variants of concern, B.1.617.2, variants, AZD1222, Surveillance, B.1.1.7, Lineage, breakthrough infections, Genomic analysis, Breakthrough infection, genomic, vaccine breakthrough infections, isolates, isolate, responsible, predominant, 【제목키워드】 India, SARS-CoV-2 vaccine, Breakthrough infection, responsible,
【저자키워드】 COVID-19, SARS-CoV-2, variants of concern, Genomic analysis, vaccine breakthrough infections, 【초록키워드】 Efficacy, Vaccine, vaccination, Vaccines, variants of concern, B.1.617.2, variants, AZD1222, Surveillance, B.1.1.7, Lineage, breakthrough infections, Genomic analysis, Breakthrough infection, genomic, vaccine breakthrough infections, isolates, isolate, responsible, predominant, 【제목키워드】 India, SARS-CoV-2 vaccine, Breakthrough infection, responsible,
{{{ 추상적인 }}}
SARS-CoV-2 돌발 감염에 대한 새로운 보고는 백신의 효능을 결정하기 위한 체계적인 게놈 감시를 수반합니다. 이 연구는 AZD1222/Covishield 및 BBV152/Covaxin을 사용한 백신 접종 후 돌발성 감염에서 분리된 균주의 게놈 분석을 자세히 설명합니다. 2021년 4월부터 5월까지 델리에서 발생한 사례 급증의 원인이 되는 우려 변종 B.1.617.2 및 B.1.1.7이 돌발 감염의 주요 혈통이었습니다.
{{ 키워드: }} 코로나19; 사스 코로나바이러스 2; 게놈 분석; 백신 돌발성 감염; 우려의 변종.